Search Results - "Klausner, Joseph"

Refine Results
  1. 1

    An Interval >7 Weeks between Neoadjuvant Therapy and Surgery Improves Pathologic Complete Response and Disease–Free Survival in Patients with Locally Advanced Rectal Cancer by Tulchinsky, Hagit, Shmueli, Einat, Figer, Arie, Klausner, Joseph M., Rabau, Micha

    Published in Annals of surgical oncology (01-10-2008)
    “…Background We assessed whether the time interval between neoadjuvant therapy and surgery affects the operative and postoperative morbidity and mortality, the…”
    Get full text
    Journal Article
  2. 2

    Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis by Barenboim, Alex, Lahat, Guy, Geva, Ravit, Nachmany, Ido, Nakache, Richard, Goykhman, Yaacov, Brazowski, Eli, Rosen, Galia, Isakov, Ofer, Wolf, Ido, Klausner, Joseph M., Lubezky, Nir

    Published in European journal of surgical oncology (01-10-2018)
    “…To assess clinical and pathologic efficacy of neoadjuvant FOLFIRINOX for locally advanced (LAPC) and borderline resectable pancreatic cancer (BRPC). Patients…”
    Get full text
    Journal Article
  3. 3

    Unique cellular interactions between pancreatic cancer cells and the omentum by Feygenzon, Valerya, Loewenstein, Shelly, Lubezky, Nir, Pasmanic-Chor, Metsada, Sher, Osnat, Klausner, Joseph M, Lahat, Guy

    Published in PloS one (20-06-2017)
    “…Pancreatic cancer is a common cause of cancer-related mortality. Omental spread is frequent and usually represents an ominous event, leading to patient death…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Innate inflammatory markers for predicting survival in retroperitoneal sarcoma by Netanyahu, Yael, Gerstenhaber, Fabian, Shamai, Sivan, Sher, Osnat, Merimsky, Ofer, Klausner, Joseph M., Lahat, Guy, Nizri, Eran

    Published in Journal of surgical oncology (01-12-2020)
    “…Introduction Existing prognostic tools for retroperitoneal sarcomas (RPS) utilize parameters that can be accurately determined only postoperatively. This study…”
    Get full text
    Journal Article
  6. 6
  7. 7

    CD11b+Ly6G+ myeloid‐derived suppressor cells promote liver regeneration in a murine model of major hepatectomy by Nachmany, Ido, Bogoch, Yoel, Sivan, Ayelet, Amar, Omer, Bondar, Ekaterina, Zohar, Nitzan, Yakubovsky, Oran, Fainaru, Ofer, Klausner, Joseph M., Pencovich, Niv

    Published in The FASEB journal (01-05-2019)
    “…ABSTRACTLiver regeneration depends on sequential activation of pathways and cells involving the remaining organ in recovery of mass. Proliferation of…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Omental Tissue-Mediated Tumorigenesis of Gastric Cancer Peritoneal Metastases by Kersy, Olga, Loewenstein, Shelly, Lubezky, Nir, Sher, Osnat, Simon, Natalie B, Klausner, Joseph M, Lahat, Guy

    Published in Frontiers in oncology (18-11-2019)
    “…The peritoneal cavity, especially the omentum, is a common site for gastric cancer metastasis, representing advanced disease stage and poor prognosis. Here, we…”
    Get full text
    Journal Article
  10. 10

    Resection Versus Observation of Small Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Tumors by Barenboim, Alex, Lahat, Guy, Nachmany, Ido, Nakache, Richard, Goykhman, Yaakov, Geva, Ravit, Osher, Ester, Scapa, Erez, Wolf, Ido, Orbach, Lior, Brazowski, Eli, Isakov, Ofer, Klausner, Joseph M., Lubezky, Nir

    Published in Journal of gastrointestinal surgery (01-06-2020)
    “…Background Management of asymptomatic, nonfunctioning small pancreatic neuroendocrine tumors (PNETs) is controversial because of their overall good prognosis,…”
    Get full text
    Journal Article
  11. 11

    Severe Postoperative Complications are Associated with Impaired Survival in Primary but not in Recurrent Retroperitoneal Sarcoma by Nizri, Eran, Netanyahu, Yael, Gerstenhaber, Fabian, Shamai, Sivan, Sher, Osnat, Merimsky, Ofer, Lahat, Guy, Klausner, Joseph M.

    Published in Annals of surgical oncology (01-05-2021)
    “…Background Retroperitoneal sarcoma (RPS) surgery entails multivisceral resection, which may cause postoperative complications. We assessed the effects of…”
    Get full text
    Journal Article
  12. 12

    R1 resection of colorectal liver metastasis – What is the cost of marginal resection? by Pencovich, Niv, Houli, Rotem, Lubezky, Nir, Goykhman, Yaacov, Nakache, Richard, Klausner, Joseph M., Nachmany, Ido

    Published in Journal of surgical oncology (01-03-2019)
    “…Background and objectives The impact of resection margins on the outcome of patients with colorectal liver metastasis (CRLM) remains controversial. We…”
    Get full text
    Journal Article
  13. 13

    Positive Histological Inflammatory Margins Are Associated With Increased Risk for Intra-abdominal Septic Complications in Patients Undergoing Ileocolic Resection for Crohn’s Disease by Shental, Omri, Tulchinsky, Hagit, Greenberg, Ron, Klausner, Joseph M, Avital, Shmuel

    Published in Diseases of the colon & rectum (01-11-2012)
    “…BACKGROUND:Rates of postoperative complications are particularly high among patients with Crohn’s disease. OBJECTIVE:The aim of this study was to assess…”
    Get full text
    Journal Article
  14. 14

    Management of endoscopic retrograde cholangiopancreatography–related perforations: Experience of a tertiary center by Weiser, Roi, MD, Pencovich, Niv, MD, PhD, Mlynarsky, Liat, MD, Berliner-Senderey, Adi, BSc, Lahat, Guy, MD, Santo, Erwin, MD, Klausner, Joseph M., MD, Nachmany, Ido, MD

    Published in Surgery (01-04-2017)
    “…Background Endoscopic retrograde cholangiopancreatography–induced perforation (EP) is a rare but severe complication. We describe the risk factors, management,…”
    Get full text
    Journal Article
  15. 15

    Protective Desmoplasia in Pancreatic Adenocarcinoma: High Vitamin D Receptor Expression and Collagen Content by BAHAT, ADI VAKNINE, BAR-DAVID, SHOSHI, BROOKS, ABIGAIL, AIZIC, ASAF, GREENBERG, ORLI, WOLF, IDO, KLAUSNER, JOSEPH M., LAHAT, GUY, NIZRI, ERAN

    Published in Anticancer research (01-11-2020)
    “…Background/Aim: Vitamin D receptor (VDR) has been shown to suppress desmoplasia in pancreatic ductal adenocarcinoma (PDAC). Our aim was to assess the clinical…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Adjuvant FOLFIRINOX in Patients with Resectable Pancreatic Cancer Is Effective but Rarely Feasible in Real Life: Is Neoadjuvant FOLFIRINOX a Better Option? by Maman, Yossi, Goykhman, Yaacov, Yakir, Oz, Barenboim, Alex, Geva, Ravit, Peles-Avraham, Sharon, Wolf, Ido, Klausner, Joseph M, Lahat, Guy, Lubezky, Nir

    Published in Cancers (03-06-2023)
    “…The recommended treatment for resectable pancreatic cancer (PC) is resection followed by adjuvant FOLFIRINOX. We assessed the proportion of patients that…”
    Get full text
    Journal Article
  19. 19

    Resection of colorectal liver metastases in the elderly-Is it justified? by Nachmany, Ido, Pencovich, Niv, Zohar, Nitzan, Goykhman, Yaacov, Lubezky, Nir, Nakache, Richard, Klausner, Joseph M.

    Published in Journal of surgical oncology (01-04-2016)
    “…Background and Objectives Liver resection of colorectal liver metastasis (CRLM) may necessitate large metabolic and physiologic reserve. As the population…”
    Get full text
    Journal Article
  20. 20

    Early reoperation following pancreaticoduodenectomy: impact on morbidity, mortality, and long-term survival by Lessing, Yonatan, Pencovich, Niv, Nevo, Nadav, Lubezky, Nir, Goykhman, Yaacov, Nakache, Richard, Lahat, Guy, Klausner, Joseph M, Nachmany, Ido

    Published in World journal of surgical oncology (31-01-2019)
    “…Reoperation following PD is a surrogate marker for a complex post-operative course and may lead to devastating consequences. We evaluate the indications for…”
    Get full text
    Journal Article